Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-06 Purchase |
2021-12-06 5:27 pm |
Outlook Therapeutics Inc. | OTLK | TRENARY C RUSSELL III CEO and President |
25,000 | $1.39 | $34,750 | 35,000 (Direct) |
View |
| 2021-12-06 Purchase |
2021-12-06 5:26 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
25,201 | $1.38 | $34,777 | 1,163,058 (Direct) |
View |
| 2021-12-03 Purchase |
2021-12-06 5:25 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
35,200 | $1.34 | $47,168 | 1,177,130 (Direct) |
View |
| 2021-12-03 Purchase |
2021-12-03 4:32 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
10,000 | $1.42 | $14,200 | 1,137,857 (Direct) |
View |
| 2021-12-02 Purchase |
2021-12-02 5:09 pm |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
10,000 | $1.39 | $13,900 | 30,000 (Direct) |
View |
| 2021-12-02 Purchase |
2021-12-02 5:08 pm |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
18,000 | $1.4 | $25,200 | 38,000 (Direct) |
View |
| 2021-12-02 Purchase |
2021-12-02 5:07 pm |
Outlook Therapeutics Inc. | OTLK | TRENARY C RUSSELL III CEO and President |
10,000 | $1.4 | $14,000 | 10,000 (Direct) |
View |
| 2021-11-29 Purchase |
2021-12-01 7:32 pm |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
16,000,000 | $1.25 | $20,000,000 | 78,799,315 (Indirect) |
View |
| 2021-04-19 Purchase |
2021-04-20 7:56 pm |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
10,000 | $1.82 | $18,200 | 20,000 (Direct) |
View |
| 2021-04-19 Purchase |
2021-04-20 7:55 pm |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
10,000 | $1.82 | $18,200 | 20,000 (Direct) |
View |
| 2021-04-20 Purchase |
2021-04-20 7:54 pm |
Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy |
10,000 | $1.83 | $18,300 | 18,926 (Direct) |
View |
| 2021-02-23 Sale |
2021-02-25 8:52 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
8,554 | $2.088 | $17,861 | 1,141,930 (Direct) |
View |
| 2021-02-23 Sale |
2021-02-25 8:51 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
15,900 | $2.088 | $33,199 | 1,127,857 (Direct) |
View |
| 2021-02-12 Sale |
2021-02-17 9:14 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
56,973 | $2.55 | $145,281 | 1,150,484 (Direct) |
View |
| 2021-02-12 Sale |
2021-02-17 9:13 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
63,700 | $2.55 | $162,435 | 1,143,757 (Direct) |
View |
| 2021-02-03 Purchase |
2021-02-04 8:54 pm |
Outlook Therapeutics Inc. | OTLK | Syntone Ventures LLC 10% Owner |
3,000,000 | $1 | $3,000,000 | 19,823,045 (Direct) |
View |
| 2021-02-02 Purchase |
2021-02-02 5:32 pm |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
8,360,000 | $1 | $8,360,000 | 32,427,067 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-01 Other |
2022-02-01 5:09 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Pillai Arun Kumar Director 10% Owner |
2,500,000 | $1.25 | 25,482,529 (Indirect) |
View |
| 2022-02-01 Other |
2022-02-01 5:05 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
2,500,000 | $1.25 | 58,316,786 (Indirect) |
View |
| 2021-12-21 Option Award |
2021-12-23 5:32 pm |
N/A 2031-12-21 |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
800,000 | $0 | 800,000 (Direct) |
View |
| 2021-12-21 Option Award |
2021-12-23 5:31 pm |
N/A 2031-12-21 |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
800,000 | $0 | 800,000 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-07 5:09 pm |
N/A 2031-10-05 |
Outlook Therapeutics Inc. | OTLK | Huang Andong Director |
22,950 | $0 | 22,950 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-07 5:08 pm |
N/A 2031-10-05 |
Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director |
25,245 | $0 | 25,245 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-07 5:07 pm |
N/A 2031-10-05 |
Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director |
44,466 | $0 | 44,466 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-07 5:06 pm |
N/A 2031-10-05 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
47,335 | $0 | 47,335 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-07 5:05 pm |
N/A 2031-10-05 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
44,753 | $0 | 44,753 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-07 5:03 pm |
N/A 2031-10-05 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
34,425 | $0 | 34,425 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:26 pm |
N/A 2031-07-06 |
Outlook Therapeutics Inc. | OTLK | TRENARY C RUSSELL III CEO and President |
4,000,000 | $0 | 4,000,000 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 6:10 pm |
N/A 2031-03-24 |
Outlook Therapeutics Inc. | OTLK | Huang Andong Director |
20,873 | $0 | 20,873 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 6:09 pm |
N/A 2031-03-24 |
Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director |
20,873 | $0 | 20,873 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 6:09 pm |
N/A 2031-03-24 |
Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director |
20,873 | $0 | 20,873 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 6:08 pm |
N/A 2031-03-24 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
20,873 | $0 | 20,873 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 6:07 pm |
N/A 2031-03-24 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
20,873 | $0 | 20,873 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 6:06 pm |
N/A 2031-03-24 |
Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director |
20,873 | $0 | 20,873 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 6:05 pm |
N/A 2031-03-24 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
20,873 | $0 | 20,873 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-11 5:46 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
1,013,627 | $1 | 62,799,315 (Indirect) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:48 pm |
N/A 2030-10-01 |
Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy |
3,668,984 | $0 | 3,668,984 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:47 pm |
N/A 2030-10-01 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
290,372 | $0 | 450,846 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:47 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
160,474 | $0.5141 | 450,846 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:46 pm |
N/A 2030-10-01 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
296,352 | $0 | 448,073 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:46 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
151,721 | $0.5141 | 448,073 (Direct) |
View |